Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOGAMULIZUMAB vs MOMETASONE FUROATE\OLOPATADINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOGAMULIZUMAB vs MOMETASONE FUROATE\OLOPATADINE: Safety Overview

Metric MOGAMULIZUMAB MOMETASONE FUROATE\OLOPATADINE
Total FAERS Reports 441 1,012
Deaths Reported 128 3
Death Rate 29.0% 0.3%
Hospitalizations 181 18
Average Patient Age 64.5 yrs 43.6 yrs
% Female Patients 38.1% 58.5%
Manufacturer Kyowa Kirin, Inc. N/A
Route INTRAVENOUS N/A